BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33986857)

  • 1. Overexpression of miRNA-22-3p attenuates osteoporosis by targeting MAPK14.
    Jia X; Yang M; Hu W; Cai S
    Exp Ther Med; 2021 Jul; 22(1):692. PubMed ID: 33986857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-140-3p aggregates osteoporosis by targeting PTEN and activating PTEN/PI3K/AKT signaling pathway.
    Yin R; Jiang J; Deng H; Wang Z; Gu R; Wang F
    Hum Cell; 2020 Jul; 33(3):569-581. PubMed ID: 32253621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation.
    Li K; Chen S; Cai P; Chen K; Li L; Yang X; Yi J; Luo X; Du Y; Zheng H
    Mol Cell Probes; 2020 Feb; 49():101479. PubMed ID: 31706013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced miR-144-3p expression in serum and bone mediates osteoporosis pathogenesis by targeting RANK.
    Wang C; He H; Wang L; Jiang Y; Xu Y
    Biochem Cell Biol; 2018 Oct; 96(5):627-635. PubMed ID: 29334613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14.
    Ji Q; Wang X; Cai J; Du X; Sun H; Zhang N
    Curr Neurovasc Res; 2019; 16(5):473-480. PubMed ID: 31713484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA-143-5p is required for the promotion of odontoblasts differentiation of human dental pulp stem cells through the activation of the mitogen-activated protein kinases 14-dependent p38 mitogen-activated protein kinases signaling pathway.
    Wang BL; Wang Z; Nan X; Zhang QC; Liu W
    J Cell Physiol; 2019 Apr; 234(4):4840-4850. PubMed ID: 30362514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of miR-128-3p through MAPK14 activation in the apoptosis of GC2 spermatocyte cell line following heat stress.
    Zou L; Cheng G; Xu C; Liu H; Wang Y; Li N; Zhu C; Xia W
    Andrology; 2021 Mar; 9(2):665-672. PubMed ID: 33089633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation.
    Sun Q; Zhang B; Zhu W; Wei W; Ma J; Tay FR
    J Dent; 2019 Mar; 82():91-97. PubMed ID: 30716449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-455-3p regulates proliferation and osteoclast differentiation of RAW264.7 cells by targeting PTEN.
    Zhang X; Wang L; Huang N; Zheng Y; Cai L; Ke Q; Wu S
    BMC Musculoskelet Disord; 2022 Apr; 23(1):340. PubMed ID: 35397519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-193-3p ameliorates bone resorption in ovariectomized mice by blocking NFATc1 signaling.
    Li X; Yang L; Guo Z
    Int J Clin Exp Pathol; 2019; 12(11):4077-4086. PubMed ID: 31933803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-433-3p promotes osteoblast differentiation through targeting DKK1 expression.
    Tang X; Lin J; Wang G; Lu J
    PLoS One; 2017; 12(6):e0179860. PubMed ID: 28628652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-25-3p regulates osteoclasts through nuclear factor I X.
    Huang Y; Ren K; Yao T; Zhu H; Xu Y; Ye H; Chen Z; Lv J; Shen S; Ma J
    Biochem Biophys Res Commun; 2020 Jan; 522(1):74-80. PubMed ID: 31740002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-128-3p enhances the protective effect of dexmedetomidine on acute lung injury in septic mice by targeted inhibition of MAPK14.
    Ding L; Gao X; Yu S; Sheng L
    J Bioenerg Biomembr; 2020 Aug; 52(4):237-245. PubMed ID: 32594289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-151a-3p Functions in the Regulation of Osteoclast Differentiation: Significance to Postmenopausal Osteoporosis.
    He Y; Chen D; Guo Q; Shi P; You C; Feng Y
    Clin Interv Aging; 2021; 16():1357-1366. PubMed ID: 34290498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-216a-3p promotes sorafenib sensitivity in hepatocellular carcinoma by downregulating MAPK14 expression.
    Wan Z; Liu T; Wang L; Wang R; Zhang H
    Aging (Albany NY); 2020 Sep; 12(18):18192-18208. PubMed ID: 33021963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-490-3p inhibits proliferation and stimulates apoptosis of ESCC cells via MAPK1 downregulation.
    Zabihula B; Yiliyasi M; Lu Y; Salai A
    Oncol Lett; 2019 Sep; 18(3):3170-3176. PubMed ID: 31452793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of bone.
    Stephens E; Roy M; Bisson M; Nguyen HD; Scott MS; Boire G; Bouchard L; Roux S
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165852. PubMed ID: 32485219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
    Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased microRNA-182-5p helps alendronate promote osteoblast proliferation and differentiation in osteoporosis via the Rap1/MAPK pathway.
    Pan BL; Tong ZW; Li SD; Wu L; Liao JL; Yang YX; Li HH; Dai YJ; Li JE; Pan L
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of microRNA-506-3p aggravates the injury of vascular endothelial cells in patients with hypertension by downregulating Beclin1 expression.
    Yi F; Hao Y; Chong X; Zhong W
    Exp Ther Med; 2018 Mar; 15(3):2844-2850. PubMed ID: 29456688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.